ACRO to establish CRO forum to interact with TransCelerate Biopharma
The Association of Clinical Research Organizations (ACRO), based in Wash. D.C., plans to constitute a CRO Forum to provide a formal mechanism for the CRO industry to furnish input into the work of TransCelerate BioPharma.
Participation in the CRO Forum, expected to begin operation in January 2015, is included as a benefit of ACRO membership.
“ACRO welcomes this opportunity to provide meaningful input on TransCelerate projects of interest to the CRO community,” said Ciaran Murray, ACRO chairman and CEO of Icon. “We have maintained a cordial but informal relationship with TransCelerate since its formation in late 2012. As CROs in general, and ACRO members in particular, often are at the forefront of implementing the innovations advanced by TransCelerate’s members, we believe the time is right for more direct interaction. We will be reaching out to the broader CRO community to gauge interest in participating in the forum.”
The CRO Forum will provide subject matter experts from participating CROs as liaisons to relevant TransCelerate workstreams. Forum representatives shall be kept apprised of workstream developments and furnish a CRO perspective on projects.